Benchmarking data helps antimicrobial stewardship programs assess the effectiveness of their efforts. Unfortunately, not all facilities have access to national benchmarking data. 

To address this, the KASIC advisory board contributed their carbapenem utilization data from 2022. A summary of carbapenem utilization from facilities across Kentucky is summarized in the carbapenem benchmark report. 

Looking to see how your carbapenem data compares? Click on the button below to access the KASIC carbapenem benchmark report.